Respiratory Infections News

Previous seasonal coronavirus infection does not provide a cross-reactive immune response against SARS-CoV-2, according to a study published in Clinical Infectious Diseases.

The COVID-19 vaccine developed by Pfizer and BioNTech appears to be effective against emerging SARS-CoV-2 variants that spread more easily than other strains, early data suggest.

Counties in the United States with large colleges or universities that held in-person learning experienced a more than 50% increase in cases of COVID-19, whereas those with remote learning saw a decline in cases, researchers reported.

Prescription fills for each of the 10 most prescribed outpatient antibiotics in the United States declined by up to 56% in April during the first peak of the COVID-19 pandemic, researchers found.

One of every 20 patients who are “COVID-19 free” will experience long-term health effects, according to a New Jersey-based health system.

According to the CDC, more than 17.2 million doses of COVID-19 vaccine have been distributed in the United States, and around 5.3 million people have received a dose.

As of Dec. 23, there were 21 confirmed cases of anaphylaxis among the first 1,893,360 recipients of the Pfizer/BioNTech COVID-19 vaccine in the United States, the CDC and FDA reported in MMWR.

The Infectious Disease Society of America has updated its guidelines for COVID-19 molecular diagnostic tests.

The American College of Obstetricians and Gynecologists says pregnant patients who meet Advisory Committee on Immunization Practices recommendations should be offered a COVID-19 vaccine.

More than 40% of antibiotics prescribed in Veterans Health Administration EDs and urgent care centers for acute respiratory infections were prescribed with an inappropriate indication, according to a study.